According to a recent LinkedIn post from ABM Respiratory Care, the company is participating in the Minnesota Society for Respiratory Care Summit in Waite Park, Minnesota, from May 3 to 5. The post highlights booth activities focused on the BiWaze platform, which is positioned as advancing airway clearance therapy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post notes that Sharon Ritter is presenting a continuing respiratory care education session on oscillating lung expansion therapy and will be available at the booth for follow-up questions. It also points to live, hands-on demonstrations of BiWaze Cough and BiWaze Clear devices, emphasizing their use across hospital and home-care settings.
The post further suggests that attendees can learn about technical features such as a dual blower system enabling bi-directional control of inhalation and exhalation. It also references recent clinical studies that reportedly examine how a closed breathing circuit may support mucus mobilization and aerosol deposition.
For investors, visibility at a professional summit and association with continuing education could help ABM Respiratory Care build credibility among respiratory therapists and clinicians. This type of clinician-focused engagement may support future adoption of the BiWaze product line and potentially contribute to revenue growth if it translates into broader clinical use.
The emphasis on home-to-hospital applicability aligns with ongoing shifts toward home-based respiratory care, which could expand the addressable market for the company’s devices. If the clinical evidence referenced in the post proves compelling and leads to guideline inclusion or institutional uptake, ABM Respiratory Care could strengthen its competitive positioning within the airway clearance segment.